320 related articles for article (PubMed ID: 25157033)
1. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.
Cats EA; van der Pol WL; Tio-Gillen AP; Diekstra FP; van den Berg LH; Jacobs BC
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):502-4. PubMed ID: 25157033
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy.
Nobile-Orazio E; Giannotta C; Musset L; Messina P; Léger JM
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):754-8. PubMed ID: 23907602
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
Kuijf ML; van Doorn PA; Tio-Gillen AP; Geleijns K; Ang CW; Hooijkaas H; Hop WC; Jacobs BC
J Neurol Sci; 2005 Dec; 239(1):37-44. PubMed ID: 16154154
[TBL] [Abstract][Full Text] [Related]
6. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
7. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
Pestronk A; Choksi R
Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies in neuropathy patients by synthetic GM1 mimics.
Pukin AV; Jacobs BC; Tio-Gillen AP; Gilbert M; Endtz HP; van Belkum A; Visser GM; Zuilhof H
Glycobiology; 2011 Dec; 21(12):1642-50. PubMed ID: 21798866
[TBL] [Abstract][Full Text] [Related]
9. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
10. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro.
Heidenreich F; Leifeld L; Jovin T
J Neuroimmunol; 1994 Jan; 49(1-2):97-108. PubMed ID: 8294565
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.
Harschnitz O; van den Berg LH; Johansen LE; Jansen MD; Kling S; Vieira de Sá R; Vlam L; van Rheenen W; Karst H; Wierenga CJ; Pasterkamp RJ; van der Pol WL
Ann Neurol; 2016 Jul; 80(1):71-88. PubMed ID: 27130524
[TBL] [Abstract][Full Text] [Related]
12. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
13. Results of testing for anti-GM1 antibodies.
McCombe PA; Wilson R; Prentice RL
J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
[TBL] [Abstract][Full Text] [Related]
14. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
Niebroj-Dobosz I; Janik P; Kwieciński H
Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
[TBL] [Abstract][Full Text] [Related]
15. [Antibodies to ganglioside GM1 and Campylobacter jejuni in patients with Guillain-Barré syndrome].
Basta I; Suturkova L; Vujić A; Aleksić S; Poceva A; Paskoska A; Milenikova K; Trikić R; Apostolski S
Srp Arh Celok Lek; 2005; 133(3-4):123-8. PubMed ID: 16206698
[TBL] [Abstract][Full Text] [Related]
16. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
[TBL] [Abstract][Full Text] [Related]
17. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies.
Sudo M; Miyaji K; Späth PJ; Morita-Matsumoto K; Yamaguchi Y; Yuki N
Int Immunopharmacol; 2016 Nov; 40():11-15. PubMed ID: 27567246
[TBL] [Abstract][Full Text] [Related]
19. Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies.
Morikawa M; Kuwahara M; Ueno R; Samukawa M; Hamada Y; Kusunoki S
J Neuroimmunol; 2016 Dec; 301():35-40. PubMed ID: 27836184
[TBL] [Abstract][Full Text] [Related]
20. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry.
Susuki K; Odaka M; Mori M; Hirata K; Yuki N
Neurology; 2004 Mar; 62(6):949-56. PubMed ID: 15037698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
